Deal Flow Alert: Electra Therapeutics $183M Series C
Electra closed a $183M Series C. Pitch CTMS & lab informatics to fuel your pipeline, hit quota, and close fast with CEO Adam Rosenthal.
Published on
Do not index
Do not index
🚀 Battle Card: Electra Therapeutics
Quick trigger:
This Electra Therapeutics sales trigger opens a prime door for CTMS & lab informatics vendors.
👤 Decision Maker in the News
- Adam Rosenthal, CEO 📧 kathy@electra-therapeutics.com
💡 Why It Matters
- This Electra Therapeutics sales trigger accelerates the pivotal trial for its first-in-class SIRP-targeted rare disease candidate, signaling a surge in high-stakes immunotherapy competition. → Source
🎯 Core Pain Point
- Navigating complex regulatory & compliance hurdles
- Scaling clinical trial infrastructure quickly
💰 What to Pitch
- Primary: Clinical Trial Management System (CTMS) → Reduce trial setup time by 30%
- Expansion: Lab Informatics Platform → Streamline R&D data workflows
🗺️ Quick Context
- HQ: South San Francisco, CA
- Employees: ≈ 75
- Rev: ≈ $0 M
- Website: electra-therapeutics.com
🤼 Competitive Intel
*Which other vendors you’ll probably face to win Electra Therapeutics’s business.*
- Veeva Systems — CTMS / eTMF
- Unique edge: End-to-end cloud suite tailored for life sciences
- Evaluated by CEO & VP Ops for regulatory compliance
- Medidata — CTMS / Rave
- Unique edge: Advanced analytics & trial design tools
- Evaluated by Head of Clinical for data insights
- Oracle Health Sciences — CTMS
- Unique edge: Scalable global trial platform
- Evaluated by IT & Clinical Ops for security
- Benchling — Lab Informatics
- Unique edge: Unified R&D data management
- Evaluated by Head of R&D for collaboration
✅ Do-Now Checklist
Connect with Adam Rosenthal via email and introduce your CTMS offering
Add the Electra Therapeutics sales trigger to your first email subject line
Generate email + DM with the Copy-My-Prompt block (Step 7) and send first touch
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Get intel like this daily—no fluff, all pipeline.
Subscribe to NewsletterForLeads
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑<your company>❑
OFFER_BRIEF = ❑<1-line value>❑
PROOF_METRIC = ❑<metric>❑
CTA_STYLE = ❑quick_call | case_study❑
TONE = ❑friendly | punchy❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Adam
COMPANY = Electra Therapeutics
DEPT = Clinical Operations
SIZE = 75
BOTTLENECK = scaling clinical trial infrastructure quickly
EVENT = Raises $183M Series C
DETAIL = just-launched pivotal trial for its rare disease candidate
PAIN = navigating complex regulatory & compliance hurdles
SRC = https://vcnewsdaily.com/electra-therapeutics/venture-capital-funding/hsbsrqwwjj
SIM_CO = Medidata
WIN_METRIC = 30% reduction in trial setup time
NEXT_SIZE = 150
EMP_EST = ≈ 75
REV_EST = ≈ $0M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: 75-person Clinical Operations
Adam—noticed your Clinical Operations team is ≈ 75.
That’s when scaling clinical trial infrastructure quickly slows growth.
We helped Medidata fix this with ❑<1-line value>❑.
Result: 30% reduction in trial setup time.
Quick call?
PS—next bottleneck hits ≈ 150.
DM ≤45 words, TONE:
Saw your post about just-launched pivotal trial for its rare disease candidate — navigating complex regulatory & compliance hurdles.
❑<1-line value>❑. ❑<metric>❑.
Quick chat?